Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a pharmacy partner by Cycle ...
July 2025: Taiho Oncology and Taiho Pharmaceutical announced the FDA’s acceptance of a supplemental New Drug Application for ...
The number of diagnosed prevalent drug-treated mHSPC cases in the 8MM will rise from 196,867 in 2025 to 244,101 by 2033.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback